Updates are available Correction dated 2019-11-18
Click to view Correction: https://doi.org/10.1186/s12920-019-0617-1
-
Authors
Parker, Margaret M.
Chase, Robert P.
Lamb, Andrew
Reyes, Alejandro
Saferali, Aabida
Yun, Jeong H.
Himes, Blanca E.
Silverman, Edwin K.
Hersh, Craig P.
Castaldi, Peter J.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL125583, R01HL130512, R01HL124233, R01HL126596, R01HL089897, R01HL089856, T32HL007427)
National Human Genome Research Institute (R01HG005220)
- License Information
-
More Information
Article History
Received: 25 April 2017
Accepted: 2 October 2017
First Online: 6 October 2017
Change Date: 18 November 2019
Change Type: Correction
Change Details: Following publication of the original article [1], the authors provided an updated accession number in the “Availability of data and materials” section of the declarations.
Ethics approval and consent to participate
: This study was approval by the Institutional Review Boards of all involved universities. For a complete list, see Additional file . Written informed consent was obtained for all subjects.
: This manuscript does not contain individual person’s data in any form. Data presented is not identifiable.
: PJC reports person fees from GlaxoSmithKline. EKS reports grants and other support from COPD Foundation, grants and personal fees from GlaxoSmithKline, personal fees from Merck and personal fees and other expense payments from Novartis, outside the submitted work. CPH reports personal fees from CSL Behring, personal fees from Mylan, outside the submitted work. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
